Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by equities researchers at Morgan Stanley from an "equal weight" rating to an "overweight" rating in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The firm currently has a $25.00 target price on the real estate investment trust's stock. Morgan Stanley's price objective indicates a potential upside of 23.09% from the stock's previous close.
DOC has been the subject of a number of other research reports. Wells Fargo & Company cut their target price on shares of Healthpeak Properties from $23.00 to $22.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 10th. Robert W. Baird lifted their price objective on Healthpeak Properties from $24.00 to $25.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 30th. Royal Bank of Canada increased their target price on Healthpeak Properties from $25.00 to $26.00 and gave the company an "outperform" rating in a report on Monday, November 4th. Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. Finally, Deutsche Bank Aktiengesellschaft raised Healthpeak Properties from a "hold" rating to a "buy" rating and increased their price objective for the company from $20.00 to $28.00 in a research note on Monday, October 21st. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $24.15.
Read Our Latest Research Report on Healthpeak Properties
Healthpeak Properties Price Performance
NYSE DOC traded up $0.17 during mid-day trading on Wednesday, hitting $20.31. The stock had a trading volume of 2,636,608 shares, compared to its average volume of 3,758,577. The company has a 50 day simple moving average of $20.98 and a 200 day simple moving average of $21.48. The company has a market cap of $14.21 billion, a price-to-earnings ratio of 43.21, a P/E/G ratio of 2.31 and a beta of 1.14. Healthpeak Properties has a 52-week low of $16.01 and a 52-week high of $23.26. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.32). The firm had revenue of $700.40 million during the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a net margin of 12.10% and a return on equity of 3.53%. The firm's revenue for the quarter was up 25.9% on a year-over-year basis. During the same period last year, the company posted $0.45 EPS. Equities analysts forecast that Healthpeak Properties will post 1.8 EPS for the current fiscal year.
Institutional Investors Weigh In On Healthpeak Properties
Several hedge funds have recently modified their holdings of DOC. State Street Corp purchased a new position in Healthpeak Properties during the third quarter worth approximately $1,093,576,000. Geode Capital Management LLC purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth $403,898,000. Charles Schwab Investment Management Inc. purchased a new position in shares of Healthpeak Properties in the 3rd quarter worth $230,988,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in Healthpeak Properties in the third quarter valued at $175,697,000. Finally, Sumitomo Mitsui Trust Group Inc. purchased a new stake in Healthpeak Properties during the third quarter valued at about $102,615,000. 93.57% of the stock is owned by institutional investors and hedge funds.
About Healthpeak Properties
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Articles
Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.